Dysmyelinating and demyelinating Charcot-Marie-Tooth disease associated with two myelin protein zero gene mutations

Hanna Drac1, Dagmara Kabzińska, Izabela Moszyńska

  • 1Neuromuscular Unit, Mossakowski Medical Research Centre, Polish Academy of Sciences, Pawińskiego 5, 02-106, Warsaw, Poland.

Journal of Applied Genetics
|November 26, 2010
PubMed

Insights

Researchers identified novel myelin protein zero (MPZ) gene mutations in Polish Charcot-Marie-Tooth (CMT) patients. These findings link specific MPZ mutations to distinct neuropathy types, aiding in prognosis for hereditary motor and sensory neuropathies.

Area of Science:

  • Genetics
  • Neurology
  • Molecular Biology

Background:

  • Mutations in the myelin protein zero (MPZ) gene are a common cause of hereditary motor and sensory neuropathies (HMSN), also known as Charcot-Marie-Tooth (CMT) disorders.
  • Establishing phenotype-genotype correlations in MPZ mutations is crucial for predicting CMT prognosis and outcomes.

Purpose of the Study:

  • To investigate MPZ gene mutations in a cohort of 67 Polish patients with demyelinating neuropathy.
  • To identify novel MPZ mutations and correlate them with clinical phenotypes in Polish CMT families.

Main Methods:

  • Genetic analysis of the MPZ gene in 67 patients from CMT families.
  • Segregation analysis to confirm mutation inheritance.
  • Clinical phenotyping of affected individuals.
  • Morphological examination of sural nerve biopsies.

Main Results:

  • Two novel MPZ gene mutations, Ile135Thr and Pro132Leu, were identified in two Polish CMT families.
  • The Pro132Leu mutation was associated with a severe, early-onset dysmyelinating-hypomyelinating neuropathy.
  • The Ile135Thr substitution correlated with the classical phenotype of CMT1.
  • Morphological data from sural nerve biopsies provided evidence of hypomyelination-dysmyelination in the Pro132Leu mutation family.

Conclusions:

  • The study identified two new MPZ mutations in the Polish population, expanding the spectrum of known MPZ-related neuropathies.
  • Distinct MPZ mutations correlate with specific clinical presentations and pathological findings in CMT.
  • These findings contribute to a better understanding of genotype-phenotype correlations in MPZ-associated neuropathies, aiding in clinical management and genetic counseling.

Related Concept Videos

Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Nervous Tissue: Myelin01:25

Nervous Tissue: Myelin

The myelin sheath is a multilayered lipid and protein covering that insulates the axon of a neuron, enhancing the speed of nerve impulse conduction. Axons without this sheath are referred to as unmyelinated. Two types of neuroglia, Schwann cells in the peripheral nervous system (PNS) and oligodendrocytes in the central nervous system (CNS) are responsible for producing myelin sheaths.
Schwann cells begin to form myelin sheaths around axons during fetal development. They wrap around a small...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...